GEHC
GE HealthCare Technologies Inc.
NASDAQ: GEHC · HEALTHCARE · MEDICAL DEVICES
$61.70
+1.35% today
Updated 2026-06-05
Market cap
$29.65B
P/E ratio
15.63
P/S ratio
1.41x
EPS (TTM)
$4.17
Dividend yield
0.22%
52W range
$59 – $90
Volume
5.0M
WallStSmart proprietary scores
57
out of 100
Grade: C+
Hold
Investment rating
4.0
Growth
C4.5
Quality
C6.0
Profitability
B5.7
Valuation
C+2/9
Piotroski F-Score
Weak
1.3
Altman Z-Score
Distress
—
Industry rank
—
View all highly rated stocks (75+) →202 stocks currently score above 75
Price targets
Analyst target
$89.75
+45.46%
12-Month target
$70.85
+14.83%
Intrinsic (DCF)
—
Margin of safety
—
3 Strong Buy9 Buy6 Hold0 Sell0 Strong Sell
Price chart
Stock snapshot
Strengths
+ Free cash flow $112.00M — positive
Risks
- Piotroski 2/9 — weak financial health
- Altman Z 1.34 — distress zone
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM | 2026 (E) |
|---|---|---|---|---|---|---|
| Revenue | $18.34B | $19.55B | $19.67B | $20.63B | $20.98B | $22.1B |
| Net income | $1.92B | $3.10B | $1.99B | $2.08B | $389.00M | — |
| EPS | — | — | — | — | $4.17 | $5.17 |
| Free cash flow | $1.80B | $1.71B | $1.55B | $1.51B | $112.00M | — |
| Profit margin | 10.45% | 15.88% | 10.13% | 10.10% | 9.10% | — |
Peer comparison
Smart narrative
GE HealthCare Technologies Inc. trades at $61.70. representing a P/E of 15.63x trailing earnings. Our Smart Value Score of 57/100 indicates the stock is fair. The company scores 2/9 on the Piotroski F-Score. With an Altman Z-Score of 1.34, it sits in the distress. TTM revenue stands at $20.98B. with profit margins at 9.10%.
Frequently asked questions
What is GE HealthCare Technologies Inc.'s stock price?
GE HealthCare Technologies Inc. (GEHC) trades at $61.70, on a P/E of 15.6x and a P/S of 1.4x. Those multiples show what the market is paying for each dollar of earnings and sales, which is the real starting point for judging whether the price is reasonable.
Is GE HealthCare Technologies Inc. overvalued?
GE HealthCare Technologies Inc. carries a Smart Value Score of 57/100 (Grade C+), which we rate Hold. That score blends growth, quality, and valuation into one read.
What is the price target of GE HealthCare Technologies Inc. (GEHC)?
The 12-month analyst consensus target is $89.75, about 45.5% above the current $61.70. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.
What is the future stock price of GEHC by 2030?
Our research-backed model puts the 2030 base case at $703.50, built from revenue projections, a growth-adjusted P/S multiple, net debt, and share dilution. It is a scenario rather than a prediction, and the bull and bear cases around it matter more than the single number when you are sizing a position.
What is GE HealthCare Technologies Inc.'s revenue?
GE HealthCare Technologies Inc.'s trailing twelve-month revenue is $20.98B, and our model projects it reaching about $26.70B by 2030. Revenue scale anchors the valuation multiples and shows whether growth is reaching the top line, so it is best read alongside margin and growth trends to see if that revenue is getting more profitable over time.
Altman Z-Score?
GE HealthCare Technologies Inc.'s Altman Z-Score is 1.34, which places it in the distress. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.
Company info
SectorHEALTHCARE
IndustryMEDICAL DEVICES
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio1.41x
ROE14.11%
Beta0.86
50D MA$66.07
200D MA$74.86
Shares out0.45B
Float0.45B
Short ratio—
Avg volume5.0M
Performance
1 week+0.00%
1 month+6.44%
3 months-8.62%
YTD-21.15%
1 year—
3 years—
5 years—